New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
HilleVax, Inc.
HLVX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

85M

Biotechnology

Next Earning date - 08 May 2025

85M

Biotechnology

Next Earning date - 08 May 2025

1.69USD

Shape0.04 ( 2.42%)
Market Closed (as of Apr 17, 20:00 EDT)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-41%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

90%
OverviewChart

Quote Panel

Shape
Updated April 18, 2025
1W 0.60 % 1M -3.43 % 3M -11.05 % 1Y -86.26 %

Key Metrics

Shape

  • Market Cap

    84.74M

  • Shares Outstanding

    50.14M

  • Share in Float

    22.76M

  • Dividende

    0

  • Earning Date

    08 May 2025

  • Price Target

    1.69

  • Average Volume

    191429

  • Beta

    0.857

  • Range

    1.34-16.305

  • Industry

    Biotechnology

  • Website

    https://www.hillevax.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

HLVX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.36

Shape-100%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

downgrade

Previous: Not converted

2024-07-09

Now: Neutral

Guggenheim

downgrade

Previous: Buy

2024-07-08

Now: Neutral

SVB Leerink

initialise

Previous: Not converted

2022-05-25

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2022-05-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.71
vs -10.06

Q2.23

arrow
arrow

N/A

-0.74
vs -2.03

Q3.23

arrow
arrow

N/A

-0.81
vs -0.45

Q4.23

arrow
arrow

N/A

-0.78
vs -0.56

Q1.24

arrow
arrow

N/A

-0.97
vs -0.71

Q2.24

arrow
arrow

N/A

-0.83
vs -0.74

Q3.24

arrow
arrow

N/A

-0.52
vs -0.81

Q4.24

arrow
arrow

N/A

-0.35
vs -0.78

Q1.25

arrow
arrow

N/A

-0.36
vs -0.97

Q2.25

arrow
arrow

N/A

-0.35
vs -0.83

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 2.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-11%

-0.11
vs -0.07

Q2.23

arrow
arrow

-13%

-0.13
vs -0.11

Q3.23

arrow
arrow

-11%

-0.11
vs -0.13

Q4.23

arrow
arrow

-14%

-0.14
vs -0.11

Q1.24

arrow
arrow

-20%

-0.20
vs -0.14

Q2.24

arrow
arrow

-20%

-0.20
vs -0.20

Q3.24

arrow
arrow

-14%

-0.14
vs -0.20

Q4.24

arrow
arrow

-22%

-0.22
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

61

61
vs 56

9%

Q2.23

arrow
arrow

54

54
vs 61

-11%

Q3.23

arrow
arrow

68

68
vs 54

26%

Q4.23

arrow
arrow

69

69
vs 68

1%

Q1.24

arrow
arrow

80

80
vs 69

16%

Q2.24

arrow
arrow

91

91
vs 80

14%

Q3.24

arrow
arrow

79

79
vs 91

-13%

Q4.24

arrow
arrow

76

76
vs 79

-4%

Earnings Growth

Latest News

HLVX

accesswire.com

7 hours ago

HilleVax, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by HilleVax (HLVX)
HLVX

accesswire.com

7 hours ago

Levi & Korsinsky Investigates Possible Securities Fraud Violations by HilleVax, Inc. (HLVX)
HLVX

accesswire.com

7 hours ago

Investors who lost money on HilleVax, Inc. should contact Levi & Korsinsky about an ongoing investigation - HLVX
HLVX

businesswire.com

8 hours ago

Frazier Life Sciences Appoints Aditya Kohli to Partner
HLVX

zacks.com

13 hours ago

What Makes HilleVax (HLVX) a New Buy Stock
HLVX

globenewswire.com

17 hours ago

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress